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The vacuolar-type H+-ATPases (V-ATPase) are a family of multi-subunit ATP-dependent proton pumps involved in a wide variety of
physiological processes. They are present in endomembrane organelles such as vacuoles, lysosomes, endosomes, the Golgi apparatus,
chromaffin granules and coated vesicles, and acidify the luminal pH of these intracellular compartments. They also pump protons across the
plasma membranes of specialized cells including osteoclasts and epithelial cells in kidneys and male genital tracts. Here, we briefly
summarize our recent studies on the diverse and essential roles of mammalian V-ATPase.
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Eukaryotic cells contain highly differentiated single-
membrane organelles including Golgi apparatus, endo-
somes, secretory vesicles, lysosomes and synaptic vesicles.
These endomembrane organelles are involved in various
basic cellular processes including (1) directional sorting of
proteins and lipids; (2) receptor-mediated endocytosis and
recycling; (3) protein degradation and processing; (4) neural
and hormonal signal transduction [1,2]. They are also
essential for specific functions of specialized tissues or
cells, including antigen presentation [3] and cytotoxicity
[4], blood clotting [5], bone remodeling [6], and the
regulation of growth factors and hormones [7]. One of the
common features of these organelles is their luminal acidic
pH. The acidic lumen is important for vesicle trafficking [8],0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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having optimal acidic pH [9,10]. The luminal acidification
is carried out mainly by a highly conserved multi-subunit
enzyme, the vacuolar-type proton ATPase or V-ATPase. It
uses the energy of ATP hydrolysis to transport protons
across membranes (for reviews, see Refs. [11–14]).
In this article, we briefly summarize our recent studies on
the essential but diverse roles of mammalian V-ATPase and
emphasize the recent progress on its involvement in protein
targeting and vesicle transport.2. Structure, regulation and catalytic mechanism of
V-ATPase
V-ATPase is structurally and evolutionarily related to F-
ATPase (ATP synthase), which is responsible for ATP
synthesis in mitochondria, chloroplast and bacteria, al-
though the physiological roles of these two enzymes are
completely different [15]. The V-ATPase consists of two
major functional sectors known as V1 and Vo (Fig. 1). The
V1 sector comprises at least eight different subunits (A–H).
Fig. 1. Subunit organization of V-ATPase and F-ATPase. The structures of V-ATPase and F-ATPase are schematically shown together with catalysis and proton
transport. Membrane intrinsic (Vo, Fo), and peripheral (V1, F1) sectors, the catalytic hexamer, stalk regions and proton pathway are indicated.
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formed from the A and B subunits. The Vo sector containing
up to five subunits (a, c, cV, cU and d) is responsible for
proton translocation across the membranes [16].
The multi-subunit V-ATPase is regulated at several
levels. The enzyme with distinct isoforms is localized in
different compartments within a single cell, or to different
cell types in a multicellular system [17–24]. The genome of
the yeast Saccharomyces cerevisiae encodes two a subunit
isoforms (Vph1p and Stv1p) for V-ATPase. They are
different in energy-coupling efficiency (H+/ATP ratio), sub-
cellular localization (the vacuole and the late Golgi com-
partment, respectively), and metabolic regulation for subunit
association under cellular conditions [25–27]. The Vph1p-
containing V-ATPase is localized to the vacuolar membrane
and required for acidification of the central vacuoles,
whereas the Stv1p-containing enzyme is needed for acidi-
fication of the lumen of Golgi apparatus and prevacuolar
compartments [25–27]. The C. elegans genome encodes
four a subunits that differ in cell type localization and
expression during developmental stages [19]. Four a subunit
isoforms have been identified in mouse, of which a1, a2 and
a3 are expressed ubiquitously, whereas a4 is kidney specific
[18,23,24,28]. Four a isoforms have also been found in man
[29]. Since they are related to specific cell functions and
diseases, many aliases have been used. Nomenclature for
the a subunit genes together with other subunits is revised
recently [29]. Immunostaining with a isoform-specific anti-
bodies revealed that the a3 was co-localized with lamp2
(lysosome associated membrane protein 2), a marker for late
endosomes and lysosomes [22]. The signal for GM130, a
cis-Golgi marker, overlapped with both a1 and a2, suggest-
ing that these isoforms are localized to the Golgi complex in
NIH3T3 and RAW264.7 cells, a lymphocyte derived cellline [22]. Furthermore, a1 was also localized to organelles
other than lysosomes/late endosomes or the Golgi apparatus
[22]. As discussed below, in addition to the a isoforms,
isoforms of the V1 subunits may also be involved in tissue-
specific functions of enzymes [12,30].
Although V-ATPase translocates protons into the lumen
of endomembrane organelles, the luminal pH is also regu-
lated by a variety of factors. Continuous proton influx into
an organelle would result in the generation of a net inside-
positive membrane potential that would inhibit further
proton translocation. It is believed that inwardly directed
Cl channels, as well as cation channels, play an essential
role in regulating the pH of an organelle (reviewed in Refs.
[11,12]). The Cl channels, in turn, may be regulated by
protein kinase A-dependent phosphorylation [31]. Endo-
membrane organelles such as yeast vacuoles have a Na+/
H+ exchanger, which increases luminal pH. The endomem-
brane exchanger has been shown to be different from that of
plasma membrane [32]. Other regulatory features include
reversible dissociation–reassembly of V-ATPase complex,
changes in the coupling efficiency between ATP hydrolysis
and proton transport, and low-molecular-mass activator and
inhibitor proteins (reviewed in Refs. [13,33]).
It has been established that F-ATPase exhibits rotational
catalysis [34–36]. The catalytic sites (each in the h subunit)
of F-ATPase alternate during ATP synthesis/hydrolysis, and
protons are transported through a pathway formed from one
single subunit a and a single of multiple (f 10) c subunits.
The catalysis and proton transport is coupled with relative
rotation of a complex of the subunit g and c ring to that of
the a3h3yab2. It has been speculated that V-ATPase has a
rotary mechanism, although V-ATPase is significantly dif-
ferent from F-ATPase in subunit composition, kinetics and
physiological roles [13,35]. We were prompted to examine
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tag to the c and G subunits of V-ATPase, respectively [37].
Upon addition of ATP, we observed continuous counter
clockwise rotation of an actin filament connected to the G
subunit of the enzyme, which has been immobilized on a
glass surface through the histidine-tag. Although two copies
of subunit G are present in V1 sector [38], rotation of only a
single actin filament connected was observed. It is possible
that physical perturbation may occur, if the enzyme con-
nects with two actin filaments simultaneously. This rotation
is inhibited by concanamycin, a specific V-ATPase inhibitor,
but not by azide, an inhibitor of F-ATPase. Since bafilomy-
cin, a similar antibiotic to concanamycin, has been shown to
bind to Vo [39–41], possibly to its subunit a [42], the
rotation of the a subunit was obviously blocked by this
tightly bound antibiotic. These results suggest that V-
ATPase and F-ATPase carry out similar rotational catalysis.
However, the different structures of the membrane sectors
(ab2c10-14 and ac4cVcUd for E. coli Fo and yeast Vo,
respectively) and stators of the two enzymes (a3b3de and
A3B3CDEFG2H for E. coli F1 and V1, respectively) (Fig. 1)
suggest that their individual mechanisms may be different.
In addition, V-ATPase subunit rotation may be also affected
by its subunit isoforms of both the membrane sector and the
stalk region.3. Luminal acidification and endocytosis
The endocytic pathway receives cargos from the cell
surface via endocytosis, biosynthetic cargos from the late
Golgi complex, and various molecules from the cytoplasm
via autophagy. The relationship between V-ATPase func-
tions and the endocytosis processes is intriguing. Various
lines of evidence demonstrate that the perturbation of
acidification of the intracellular compartments in yeast or
mammalian cells causes defective endocytosis (for review
see Ref. [1]). We demonstrated that the luminal acidification
of the intracellular compartments was abolished in cells
derived from blastocyst embryos with deletion in the gene
encoding the proteolipid c subunit [43]. The mutant cells
exhibited a significant defect in endocytosis. When cells of
outgrowths of wild-type blastocysts were incubated with the
extracellular fluorescein isothiocyanate-labeled dextran
(FITC-dextran), it was accumulated within cells as a punc-
tate lysosome-like pattern. However, the fluorescence
remained at the cell surface of the null mutant cells, and
the lysosomal staining pattern was not observed [43]. In
addition, the morphology of the Golgi apparatus in the
mutant cells was vacuolated, especially in the trans region,
possibly due to the unbalance of the ion homeostasis. These
results demonstrate that impaired luminal acidification
causes defects in the intracellular vesicle trafficking required
for protein processing/degradation.
The tight correlation between endocytosis and endosomal
acidification is also observed in kidney proximal tubuleepithelial cells. These cells have an extensive apical endo-
cytotic apparatus critical for the reabsorption and degrada-
tion of proteins that traverse the glomerular filtration barrier
[44]. Inhibition of V-ATPase through reagents including
folimycin and cadmium abolishes albumin uptake and
causes Fanconi-like syndrome, with impaired reabsorption
in the proximal tubule [45]. Moreover, a mutation in chloride
channel 5 of the ClC family (ClC5), which, together with V-
ATPase, is believed to be responsible for efficient endosomal
acidification in the proximal tubule, results in Dents’s
disease, which resembles the Fanconi’s syndrome [46,47].
ClC5 knockout mice show similar defect [48].
The role of the V-ATPase and its individual subunit in
endocytosis is also shown when human and simian cells
were infected with immunodeficiency viruses (HIV and
SIV) [49]. H subunit of V1 sector has been shown to bind
to the adaptor protein (AP2) complex, which is involved in
the internalization of proteins from the plasma membrane to
early endosomes [50]. The same subunit also binds to Nef,
an accessory protein of HIV and SIV, which is required for
efficient viral pathogenicity [51,52]. Blocking the expres-
sion of H subunit decreased the enhancement of virion
infectivity by Nef [49]. The Vma13p, the yeast counterpart
of subunit H, is implicated in structural and functional
coupling of the V-ATPase [53–55]. However, it is still not
clear whether the entire V-ATPase is required for the
functions of H subunit in intracellular vesicle sorting.
In kidney proximal tubule epithelial cells, it has been
shown that recruitment of the GDP/GTP exchanger factor
ARNO (ADP-ribosylation factor nucleotide binding site
opener), and its cognate small GTPase ADP-ribosylation
factor 6 (Arf 6), to endosomal membrane is dependent on
the luminal acidification by V-ATPase [56]. The recruitment
of Arf to target membranes is an early step in the regulation
of vesicle trafficking. The detailed mechanism of the pH-
dependent coat protein recruitment is not clear, and the pH-
sensing proteins in endosomal membranes remain to be
demonstrated.4. Regulated secretion and V-ATPase
Many cells types are capable of accumulating newly
synthesized proteins or small molecules (neurotransmitters,
hormones, and enzymes) into storage granules or micro-
vesicles whose exocytosis can be stimulated in response to
extracellular signals. The mature secretory granules have a
final luminal pH of 5.0–5.5 [57–59]. Acidification plays
multiple roles in secretory granule formation which include
conversion of the granule contents to their mature forms,
condensation of granule content, and recently it has been
shown that the acidic pH may be important in priming
preexisting granules for exocytosis [60]. Thus, V-ATPase
inhibitors block the formation of mature secretory granules
and cause the accumulation of large vacuolar structures near
TGN (trans Golgi network) [43,61].
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secretory cells, some cells, including T cells, platelets,
dendritic cells, melanocytes and osteoclasts, etc., store their
secretory proteins in their lysosome. These lysosomes can
undergo regulated secretion and are defined as ‘‘secretory
lysosomes’’.
4.1. Osteoclast
Osteoclasts—which are derived from the hematopoeitic
linage—resorb bone by the fusion of their lysosomes with
the plasma membrane [62–64]. The resorption process
requires the secretion of protons and proteolytic enzymes
by osteoclasts. The maintenance of the acidic environment
is required for dissolution of bone minerals and degradation
of the bone matrix [6]. The proton pumps highly concen-
trated at the osteoclast ruffled border (apical surface) are V-
ATPases [65].
We have found that the a3 isoform is specifically
localized in the plasma membrane and its vicinity of
osteoclasts derived from bone marrow cells [23]. Consistent
with this localization, disruption of the Atp6i (TCIRG1)
gene for mouse a3 causes severe osteopetrosis. Osteoclasts
isolated from such animals failed to generate resorption pits
on bone chips [66]. A spontaneous mouse osteosclerosis
(oc) mutation [67] has been mapped to the same gene [68].
Mutations in the a3 gene account for f 50% of human
kindreds with recessive osteopetrosis, nearly all of them
being frameshift or termination mutations [69,70]. These
results indicate that the a3 isoform is an essential subunit of
the osteoclast plasma membrane V-ATPases.
However, the a3 isoform is expressed in all tissues so far
examined, and it is not restricted to osteoclasts [23,24]. We
found immunochemically that the V-ATPases with the a3
isoform are localized to late endosomes and lysosomes in
NIH3T3, RAW264.7, and other cell lines [22]. Consistent
with the immunofluorescence staining, electron microscopic
observation revealed that both the a3 isoform and lamp2
were localized to lysosome-like multi-vesicular bodies
(MVBs). Interestingly, lamp2 signal was observed on both
limiting membranes and vesicular or tubular structures
inside the MVBs, whereas the a3 localization was restricted
to the limiting membranes [22].
What is the mechanism for targeting V-ATPase with the
a3 to the osteoclast plasma membrane? The osteoclast
differentiation is activated by receptor activator of nuclear
factor nB ligand (RANKL) through interaction with osteo-
blasts [71]. The established murine macrophage cell line
RAW264.7 can form multinuclear cells when cultured in the
presence of sRANKL (the extracellular domain of RANKL)
[72]. The differentiated cells express osteoclast markers
such as tartrate-resistant acid phosphatase, calcitonin recep-
tor, c-src and cathepsin K. Thus, this cell line can be used as
a good model for examining the targeting of V-ATPases
during differentiation.Upon stimulation with sRANKL, the a3 isoform together
with a lysosome marker, lamp2, were localized in the dot-
like organelles associated with the filamentous structures of
microtubules extending to the cell surface. After 7-day
incubation, both markers were found mostly on the plasma
membranes of mature multinuclear osteoclast-like cells [22].
Immunoelectron microscopy confirmed that the a3 signal
was highly concentrated in the cell periphery and plasma
membrane facing the bone matrix. These results suggest that
lysosomal V-ATPases are targeted to the ruffled border
together with other lysosomal markers including lamp2
upon osteoclast differentiation. This is consistent with the
fact that various lysosomal enzymes, including tartrate-
resistant acid phosphatase and cathepsin K, are found in
the resorption lacunas formed between bone and the oste-
oclast ruffled border [6]. Thus, the secretory lysosome
pathway provides osteoclast plasma membrane-specific V-
ATPase and lysosomal enzymes into the resorption lacunas.
The molecular machinery underlying the lysosome fu-
sion with plasma membranes in osteoclasts remains unclear.
Several lines of evidence have suggested that transport of
vesicles containing V-ATPases from lysosome to plasma
membranes in osteoclasts is dependent on cytoskeletons. A
mouse osteopetrotic gray-lethal (gl) mutation caused defec-
tive cytoskeletal organization of osteoclasts [73,74]. As a
result, the gl mutant osteoclasts displayed an underdevel-
oped ruffled border and disorganized localization of V-
ATPase. These gl osteoclasts showed a marked reduction
in resorption function. We found that the a3 colocalization
with the filamentous structures of microtubules (Fig. 2A)
and depolymerization with nocodazol disturbed this distri-
bution [22]. In addition, it is known that RANKL–RANK
signaling pathway activates mitogen-activated protein ki-
nase (MAPK) and NF-nB indirectly [75,76]. We found that
SB203580, a p38 protein kinase inhibitor, inhibited
RANKL-induced differentiation, when SB203580 was
added to the medium on the fourth day after RAW264.7
cells were cultured in the medium containing RANKL and
M-CSF, followed with culturing for 3 days. SB203580
inhibited the distribution change of the a3 isoform, while
it has no efficiency for microtubles (Fig. 2B) (Sun-Wada,
G.-H., Oka, T., Toyomura T., Wada, Y., and Futai M.,
unpublished results). Lee et al. [77] have shown that the B
subunit of V-ATPase contains a binding site for filamentous
actin. It is possible that the lysosomes delivered to the
vicinity of the plasma membrane through microtubules
may switch tracks, and concentrated to form an active
resorption domain through interaction with microfilaments.
4.2. Lamellar bodies, lysosome-related organelles
Pulmonary alveoli are the terminal sac-like extensions of
the distal respiratory tree that are specialized for gas
exchange. The alveolar surface is covered by a phospholipid
film (pulmonary surfactant), which is synthesized in type II
epithelial cells and stored in lamellar bodies, specialized
Fig. 2. Immunofluorescence analysis of a3 localization in differentiated osteoclast-like cells. The a3 was colocalized with the microtubule structure in
osteoclast-like cells derived from RAW264.7 after being cultured for 7 days in the presence of sRANKL and M-CSF (A). The peripheral distribution of a3 was
inhibited by the addition of SB203580 on the fourth day after the differentiation was initiated (B). Scale bars, 10 Am.
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from 1.0 to 2.0 Am, contain lysosomal markers including
acid phosphatase, cathepsin, and CD63. In addition, lamel-
lar bodies have an acidic interior environment (pHf 5.5)
maintained by V-ATPases [79]. The acidic pH may be
required for the packaging of surfactant phospholipids,
processing of surfactant proteins, and surfactant protein-
dependent lipid aggregation [80]. Therefore, lamellar bodies
can be a member of secretory lysosomes.
We have found that subunit isoforms of V1 sector C2
contained two splicing variants (C2-a and C2-b) exhibiting
differential expressions in kidneys and lungs [30]. C2-a was
specifically expressed in type II alveolar epithelial cells
(type II cells) and localized to the lamellar bodies, whereasC2-b was found predominantly in the plasma membranes of
renal intercalated cells. C2-a contains 46 additional amino
acid residues (276Pro to 321Glu) compared with C2-b. A
survey of genome databases revealed that the 138-bp
insertion (46 amino acid residues) in C2-a was encoded
exactly by exon 12 among the total 15 exons of C2 isoform
gene, and C2-b is the product of mRNA skipping this exon.
This insertion was not found in the C1 isoform, or in the C
subunits of other organisms including yeast [81], plant [82]
and nematode [21]. The 46-amino-acid sequence contained
potential sites for phosphorylation by protein kinase C and
casein kinase, suggesting that sequence itself or its phos-
phorylation is required for unique V-ATPase functions in
lamellar bodies.
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Chediak–Higashi syndrome (CHS) and Hermansky–
Pudlak syndrome (HPS), which are characterized by varying
degrees of pigmentation and bleeding disorders [83]. It has
been reported that fibrous lung disease is also a significant
complication of HPS, and that morphological analysis
detected lamellar bodies of abnormal size [84]. Greatly
enlarged lamellar bodies were also detected in beige mouse,
a model of CHS characterized by giant lysosomes in
multiple tissues [85]. Analysis of the defects of the diseases
will help to understand the precise mechanism underlying
the biogenesis and secretion of lamellar bodies.
4.3. Acrosome acidification and its functions
The acrosome is a unique organelle that is formed during
spermatogenesis. During its biogenesis, numerous small
proacrosomal vesicles fuse together and form an acrosomal
vesicle. Little is known about the molecular mechanisms
that regulate the targeting and fusion of the vesicles during
acrosomal vesicle formation. The components of SNARE
[soluble N-ethylmaleimide-sensitive (NSF) receptor pro-
teins] hypothesis fusion machinery were found in mature
sea urchin sperm and probably have roles in membrane
fusion during acrosome biogenesis. In addition, it has been
shown that Hrb, a protein containing the Asn-Pro-Phe
(NPF) motif, is required for acrosome formation through
interaction with Esp15, a transport vesicle adaptor protein
with a role in endocytosis and vesicle sorting [86]. Hrb and
Esp15 form a complex and associate with the cytosolic
surface of proacrosomal vesicles. Analysis of a Hrb gene
knockout mice reveals that the proacrosomal vesicles still
form in spermatid, but that the vesicles cannot fuse, suggest-
ing that Hrb is a critical component of the vesicle-to-vesicle
docking and/or fusion machinery required for acrosome
biogenesis [86].
The sperm acrosome reaction has the characteristic hall-
marks of regulated secretion: (1) secretory products are
concentrated and condensed; (2) secretory granules are
stored for long periods of time; (3) secretion is coupled to
an extracellular stimulus (in this case, the zona pellucida)
[87]. Regulated secretion from sperm (acrosome reaction) is
obligatory for fertilization. The acrosome lumen is acidic
and contains hydrolytic enzymes that are involved in
assisting the sperm in penetration of the investment sur-
rounding the egg. The acidification of the acrosome is
carried out by a unique V-ATPase, which contains a testis-
specific E1 isoform and a2 isoform as its subunits [88]. The
E1 transcript appears about 3 weeks after birth,
corresponding to the start of meiosis, and is expressed
specifically in round spermatids in seminiferous tubules.
Immunohistochemical analysis with isoform-specific anti-
bodies revealed that the V-ATPase with the E1 and a2
isoforms is located specifically in developing acrosomes
of spermatids and acrosomes in mature sperm [88]. Inter-
estingly, the a subunit that is localized on the acrosomalmembrane is a2, an isoform localized specifically to Golgi
apparatus, not other a isoforms [22]. This is consistent with
the previous morphological observation that the acrosome is
formed through the fusion of vesicles derived from the
Golgi apparatus [89,90].
E1 isoform exhibits 70% identity with the ubiquitously
expressed E2, and both of them functionally complement a
null mutation of the yeast counterpart VMA4. The chimeric
enzymes show slightly lower Km
ATP than yeast V-ATPase.
Consistent with the temperature-sensitive growth of Dvma4
expressing E1 isoform, vacuolar membrane vesicles exhibit
temperature-sensitive coupling between ATP hydrolysis and
proton transport. This temperature sensitivity of testis-spe-
cific V-ATPase may be consistent with the lower optimal
temperature (f 33 jC) for the culture of spermatid cells
[91,92]. These results suggest that E1 isoform is essential
for the energy coupling involved in the acidification of
acrosomes.5. Perspectives
The luminal acidification and individual V-ATPase sub-
unit are required in intracellular vesicle sorting. However,
the signaling network and link between the luminal acidi-
fication and the regulatory mechanism of vesicle transport
are still not clearly understood. Recently, it has been shown
that the E subunit of the V-ATPase may interact with Dbl-
homology domain of mouse Sos1, a guanine nucleotide
exchanger factor involved in Rac1 activation [93]. Rac1
activation regulates various trafficking events, such as the
transferrin receptor-mediated clathrin-coated vesicle forma-
tion [94]. It is possible that V-ATPase itself is capable of
interacting with the signaling pathway. It is also possible
that certain domains of V-ATPase may interact with the
machinery required for vesicle trafficking.Acknowledgements
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